U.S. Markets closed

CardioGenics Holdings Inc (CGNH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0156-0.0004 (-2.5000%)
At close: 3:39PM EDT

CardioGenics Holdings Inc

6295 Northam Drive
Unit 8
Mississauga, ON L4V 1W8

Full Time Employees4

Key Executives

Dr. Yahya Abdul Gawad MB, Ch.B., M.D., MSc.Chief Exec. Officer and Director119.45kN/A59
Mr. James A. Essex CA, MBAChief Financial Officer28.67kN/A68
Ms. Linda J. Stering F.Inst.L.C.O.Sec. and DirectorN/AN/A56
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.

Corporate Governance

CardioGenics Holdings Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.